Scientist, educator, curriculum developer, and CPRS-FE/CPSS with 35 years of experience translating evidence-based science and behavioral health principles into engaging professional education. Combines lived recovery experience with expertise in adult learning, instructional design, stakeholder collaboration, and systems improvement.
Taylor Rhoades, MHA, is System Program Director for Responsible AI at Mercy and a Global Liver Institute Ambassador. His connection to liver care is deeply personal: his son, John, was diagnosed with biliary atresia at 28 days old, underwent a Kasai procedure, and ultimately received a liver transplant one day before his first birthday.
Tracie Morse is a business development and sales executive with more than 25 years experience driving growth, building strategic partnerships, and connecting organizations with the communities they serve. Her career spans hospitality, healthcare, international business, entrepreneurship, media, and event leadership, providing a broad perspective on business development, relationship management, and community engagement.
Bruce Luxon, MD, PhD is the former chairman and chief of service for the Department of Medicine at Georgetown University Hospital, Washington. He remains a vice president for clinical research at Georgetown University Medical Center. His clinical focus is in hepatology, with expertise in autoimmune hepatitis, cholestatic liver diseases and viral hepatitis, including hepatitis B and C.
Chris Burns is an Emmy Award-winning cinematographer, filmmaker, and founder of Ayumi Creative, where he has spent more than two decades creating cinematic stories for Netflix, HBO Max, A&E, Discovery, national brands, and nonprofit organizations. His work is rooted in authentic human storytelling and the power of visual media to inspire action.
Dr. Speliotes is the Keith Henley Endowed Professor of Gastroenterology and Computational Medicine and Bioinformatics at the University of Michigan. She is an internationally leader in the genetics of human obesity, MASLD, and cardiometabolic disease having identified thousands of genetic variants that cause these diseases. She developed bioinformatic methods to identify causal tissues, genes and pathways highlighted by genomic analyses.
Andrea Wilson Woods is a writer, speaker, and patient advocate dedicated to improving liver cancer outcomes. She is the founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, named after her sister, who died from the disease at age 15. With a background in teaching, storytelling, and nonprofit leadership, she blends compassion with strategic insight to drive change in healthcare. Andrea's mission is to ensure no one faces liver cancer alone, turning personal loss into a powerful force for awareness and action.
Kerry Sivia is a patient advocate living with metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune hepatitis, primary biliary cholangitis (PBC), and cirrhosis. Since receiving her diagnoses in 2021, she has become a leading voice for patient-centered advocacy in hepatology care, focusing on multidisciplinary collaboration, health equity, and the lived experience of people affected by liver disease.
Dr. Sharon H. Jaycox, PhD, MHA
Dr. Sharon H. Jaycox is a strategic healthcare and patient advocacy executive with more than 12 years of experience advancing patient-centered research, clinical development integration, health equity, and community engagement across public health, liver disease, metabolic health, and clinical research environments.
Professor of Medicine, University of Washington, Director of Hepatology, Veterans Affairs Puget Sound Health Care System.
My areas of interest include liver cancer screening and risk stratification, clinical epidemiology of chronic liver disease, cirrhosis, and HCC, prediction modeling, target trial emulation and the role of cholesterol in MASLD.